发明名称 NOVEL QUINUCLIDINE DERIVATIVES AND MEDICINAL COMPOSITIONS CONTAINING THE SAME
摘要 A compound of formula (I), wherein B is a phenyl ring, a 5 to 10 membered heteroaromatic group containing one or more heteroatoms, or a naphthalenyl, 5,6,7,8-tetrahydronaphthalenyl, benzo[1,3]dioxolyl, or biphenyl group; R<SUB>1</SUB>, R<SUB>2 </SUB>and R<SUB>3 </SUB>each independently represent a hydrogen or halogen atom, or a hydroxy group, a phenyl group, -OR<SUP>7</SUP>, -SR<SUP>7</SUP>, -NR<SUP>7</SUP>R<SUP>8</SUP>, -NHCOR<SUP>7</SUP>, -CONR<SUP>7</SUP>R<SUP>8</SUP>, -CN, -NO<SUB>2</SUB>, -COOR<SUP>7 </SUP>or CF<SUB>3 </SUB>group, or a strait or branched, substituted or unsubstituted lower alkyl group, wherein R<SUP>7 </SUP>and R<SUP>8 </SUP>each independently represent a hydrogen atom, a straight or branched lower alkyl group, or together form an alicyclic ring; or R<SUP>1 </SUP>and R<SUP>2 </SUP>together form an aromatic or alicyclic ring or a heterocyclic group. n is an integer from 0 to 4; A represents a group selected from -CH<SUB>2</SUB>-, -CH-CR<SUP>9</SUP>-, -CR<SUP>9</SUP>-CH-, -CR<SUP>9</SUP>R<SUP>10</SUP>-, -CO-, -O-, -S-, -S(O)-, -S(O)<SUB>2</SUB>- and NR<SUP>9</SUP>, wherein R<SUP>9 </SUP>and R<SUP>10 </SUP>each independently represent a hydrogen atom, a straight or branched lower alkyl group, or together form an alicyclic ring; m is an integer from 0 to 8, provided that when m=0, A is not -CH<SUB>2</SUB>-; p is an integer from 1 to 2 and the substitution in the azonia bicyclic ring may be in the 2, 3 or 4 position including all possible configurations of the asymmetric carbons; R<SUB>4 </SUB>represents a group of structure: (Formulae II) wherein R<SUP>11 </SUP>represents a hydrogen or halogen atom, a hydroxy group, an alkoxy group, a nitro group, a cyano group, -CO<SUB>2</SUB>R<SUP>12 </SUP>or -NR<SUP>12</SUP>R<SUP>13</SUP>, wherein R<SUP>12 </SUP>and R<SUP>13 </SUP>are identical or different and are selected from hydrogen and straight or branched lower alkyl groups, or a straight or branched, substituted or unsubstituted lower alkyl group; R<SUP>5 </SUP>represents an alkyl group of 1 to 7 carbon atoms, an alkenyl group containing 2 to 7 carbon atoms, or a group of formula (III) wherein q=1 or 2 and R<SUP>11 </SUP>iss a defined above; R<SUP>6 </SUP>represents a hydrogen atom, a hydroxy group, a methyl group or a -CH<SUB>2</SUB>OH group; and X<SUP>-</SUP> represents a pharmaceutically acceptable anion of a mono or polyvalent acid .
申请公布号 SI1353919(T1) 申请公布日期 2006.12.31
申请号 SI20010030596T 申请日期 2001.12.20
申请人 ALMIRALL PRODESFARMA AG 发明人 PRAT QUINONES MARIA;FERNANDEZ FORNER MARIA DOLORS;BUIL ALBERO MARIA ANTONIA
分类号 A61K31/439;A61K45/00;A61P1/00;A61P11/00;A61P13/00;A61P43/00;C07D453/02 主分类号 A61K31/439
代理机构 代理人
主权项
地址